Pulmonology

New cohort data comparing the lone regulated IPF therapies show one is associated with reduced mortality—while the other has a better continuation of care.

A story of how a clinician, mentor, father, and husband is handling the COVID-19 pandemic on the frontlines and social media.

Investigators find individuals with asthma who slept less than 5 hours per night had increased asthma attacks and overnight hospitalizations.

Despite being advised in clinical guidelines, fewer than 2% of COPD patients initiate pulmonary rehabilitation within 90 days of hospitalization.

An analysis of the CITU study is shedding light on the impact of e-cigarette use on arterial stiffness and vascular health.

Prenatal exposure to air pollutants has a lasting effect on growth after birth.

California is home of the cities with the most unhealthy pollution levels, according to the newest annual report from the ALA.

Investigators assessing the link from CO to pneumonia risk—and the benefit of biomass-fueled cookstoves in reducing them—find it is not very distinct.

Patients too frequently self-assess their pneumonia risk, therefore reducing the efficacy of preventive measures.

Can positive ELISA test results better interpret for how much longer social distancing must continue?

Dr. Rapoport of Mount Sinai discusses the clinical ingenuity fostered by the pandemic response, and what US healthcare must improve on in the near future.

Pathogenic mechanism between respiratory exposures and the development of AAV could be established in future research.

ALA chief medical officer Al Rizzo, MD, discusses plans to kickstart vaccine research and public health preventive measures.

David Rapoport, MD, explains his institutions development of emergency ventilators through a common sleep apnea device.

How the island nation has set an efficient model of care access and preparation that has allowed them to best manage COVID-19.

New research from the California Department of Public Health is shedding new light on the impact of wildfire smoke on out-of-hospital cardiac arrest.

Clinical investigator and allergist Jonathan Corren, MD, shares insight on the TSLP inhibitor.

The Proventil HFA generic approval comes at a time of greater inhaler therapy demand due to the respiratory burdens of the coronavirus.

COPD patients with unnoticed OSA are at a greater risk of hospital readmission and even all-cause mortality.

Al Rizzo, MD, of the American Lung Association, discusses some of the biggest challenges and questions raised on lung health during the coronavirus pandemic.

New findings show asthmatic children in a highly-polluted region improved in small airway function when their bedroom air was filtered.

The American Thoracic Society has released a set of guidelines to help clinicians treating patients with COVID-19.

New pivotal phase 3 findings support an upcoming sBLA for the IL4 and IL13-targeting agent.

A Vancouver-based cohort shows association between increased infancy antibiotic use, gut microbiome manipulation, and asthma development by age 5.

Discussing an editorial in the Journal of Clinical Endocrinology & Metabolism with journal editor in chief Paul Stewart, MD.